Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Dosage: This is a weekly injection
These dates are determined through extensive, long-term stability testing conducted under controlled conditions
Some individuals notice increased fatigue, muscle tightness, or reduced recovery when intake becomes lower over time
Rotating sites may help reduce localized irritation and improve consistency during longer peptide research protocols
ARHOME (AR Medicaid)
Clinical trials across all commercially available GLP-1 receptor agonists, including semaglutide, tirzepatide, liraglutide, exenatide, dulaglutide, and lixisenatide, have documented injection site reactions as a recognized adverse effect
US$ 23.35
US$ 28.85
US$ 29.26
